How customer requirements shape the development of new microalgae ingredients

A new ingredient can work perfectly in the laboratory and still be the wrong commercial product.

It may have strong biological performance, an interesting nutritional profile or a promising production process, but fail because it does not fit the customer’s formulation, specification, regulatory pathway, quality system, qualification process or supply requirements.

For emerging ingredients such as microalgae-derived oils and biomass, this distinction matters.

Commercial development should not begin with the assumption:

“We can produce this — now who will buy it?”

A stronger starting point is:

“What does the customer need the ingredient to do, and what must the product and production system deliver to meet that requirement consistently?”

That changes ingredient development from a purely technical exercise into an integrated process involving biology, processing, quality, regulation, formulation and commercial supply.

Technical success is not the same as commercial fit

In biotechnology, there is an understandable focus on technical performance.

For a microalgae platform, this can include:

• biomass productivity
• target lipid or protein concentration
• culture stability
• growth rate
• harvesting efficiency
• extraction yield
• energy demand
• processing recovery

These variables are essential.

But none of them, on their own, tells a supplier whether the finished ingredient is commercially useful.

A buyer is usually evaluating a different set of questions.

They may want to know:

• Does the ingredient meet our composition specification?
• Can we formulate with it?
• Is the flavour or odour acceptable?
• What is the shelf life?
• How is oxidation controlled?
• What documentation is available?
• What quality limits apply?
• Does it fit our regulatory pathway?
• Can the supplier produce it consistently?
• Can the supplier meet our expected volumes?
• What pack size and storage conditions are required?
• What happens when demand increases?

A commercially viable product needs both sides of that equation to work.

What do customers actually help define?

Customer requirements can influence almost every part of an ingredient programme.

Composition and specification

A customer rarely buys “microalgae” as an abstract category.

They buy a defined ingredient.

For an omega-3 product, that may mean requirements around:

• EPA concentration
• DHA concentration
• EPA:DHA ratio
• total fatty acids
• moisture
• contaminants
• microbiological limits
• oxidation values
• colour
• odour
• other compositional parameters

For a whole-cell biomass or powder, the specification may include a different set of parameters.

That specification then becomes a technical target for development.

Product format

The same biological starting material can potentially lead to very different finished ingredients.

A customer may require:

• refined oil
• concentrated oil
• encapsulated oil
• emulsion
• dry powder
• whole-cell biomass
• standardised extract

Each format creates different processing, stability, handling and packaging requirements.

A supplier therefore cannot determine the best production route without understanding the intended finished format.

Application requirements

An ingredient intended for a softgel capsule may face different technical constraints from one intended for:

• a beverage
• powder blend
• gummy
• functional food
• sachet
• tablet
• animal-nutrition formulation

The finished application can affect:

• flavour tolerance
• colour
• solubility or dispersibility
• heat exposure
• oxidation risk
• inclusion rate
• particle size
• viscosity
• packaging
• shelf-life expectations

This is why application testing should form part of qualification rather than being treated as a late-stage activity.

Quality requirements

Ingredient buyers usually work within defined quality systems.

Depending on the customer and market, they may require limits or documentation covering:

• identity
• purity
• microbiological quality
• heavy metals
• contaminants
• oxidation
• allergens
• residual processing materials
• traceability
• manufacturing controls

The US FDA, for example, places significant emphasis on identity, purity, composition and specifications for food ingredients and dietary supplements, while good manufacturing practices require manufacturers to establish and maintain appropriate specifications and controls. ([U.S. Food and Drug Administration][1])

These requirements need to be considered during product development because they influence testing, processing and supplier controls.

Documentation

For many commercial customers, the ingredient is not truly usable until the supporting documentation is acceptable.

Common documents may include:

• product specification
• Certificate of Analysis
• safety information
• manufacturing information
• traceability documentation
• allergen statement
• GMO statement where relevant
• country-of-origin information
• stability information
• regulatory documentation
• certification evidence

The exact requirements vary by customer and market.

This means documentation is not simply an administrative task at the end of product development. It needs to be designed alongside the product.

What is an ingredient specification?

An ingredient specification defines the characteristics that a product must meet.

It can include:

• identity
• chemical composition
• physical characteristics
• microbiological limits
• contaminant limits
• performance characteristics
• analytical methods
• acceptance criteria

For emerging ingredients, specification development is especially important because there may not be a mature industry standard covering every parameter.

A supplier and customer therefore need to agree what characteristics matter for the application.

For a microalgae-derived EPA ingredient, a practical specification could ultimately include criteria around:

• EPA concentration
• DHA concentration
• total fatty-acid profile
• peroxide value
• anisidine value
• moisture
• heavy metals
• microbiological limits
• appearance
• odour
• storage requirements

The final specification would depend on the actual product, processing route, customer and target market.

NuFoods has not yet established a final commercial specification; this is part of the development and qualification work that Phase 1 is intended to inform.

Why does a Certificate of Analysis matter?

A Certificate of Analysis, or CoA, reports test results for a particular batch against the defined product specification.

A CoA does not replace the specification.

The specification establishes what is acceptable.

The CoA demonstrates how a specific batch performed against those requirements.

In well-developed supply relationships, customers may also evaluate whether the supplier’s analytical methods and controls are reliable.

Regulatory guidance in other regulated ingredient sectors illustrates the broader principle: Certificates of Analysis are useful only where suppliers have systems capable of consistently producing and testing material against defined specifications. ([U.S. Food and Drug Administration][2])

For a developing ingredient supplier, this reinforces the importance of building analytical capability alongside cultivation and processing.

Why stability needs to be considered early

An ingredient can meet specification when it leaves the production line and still fail commercially if it deteriorates during storage or use.

Stability is especially important for long-chain polyunsaturated fatty acids such as EPA and DHA because they are susceptible to oxidation.

Relevant development questions include:

• How does the ingredient behave over time?
• What temperature should it be stored at?
• What packaging is appropriate?
• How much oxygen exposure is acceptable?
• Are antioxidants needed?
• What happens after the package is opened?
• Does the ingredient remain within specification through its intended shelf life?

FDA food-ingredient guidance similarly treats stability as an important consideration for ingredients sensitive to environmental conditions such as air, moisture or temperature. ([U.S. Food and Drug Administration][3])

That makes stability a product-development question, not just a warehouse question.

Why qualification should start before commercial scale

Customer qualification can involve several functions within the buyer’s organisation.

Depending on the company, these may include:

• R&D
• formulation
• quality assurance
• regulatory
• procurement
• supply chain
• manufacturing
• commercial teams

Qualification can require several stages.

Initial technical review

The customer reviews the proposed ingredient, specification and supporting information.

Analytical sample

Small quantities may be used for laboratory analysis or initial formulation screening.

Application testing

The ingredient is tested within the customer’s actual product or process.

Specification review

The buyer and supplier confirm whether the proposed specification is fit for purpose.

Quality and regulatory review

Documentation, manufacturing controls and regulatory status are evaluated.

Larger trial quantities

More representative quantities may be required for pilot production or manufacturing trials.

Commercial approval

Only after technical, quality, regulatory and commercial requirements are sufficiently resolved can recurring supply begin.

This process can take considerable time.

If a supplier waits until a commercial plant is already designed and built before discovering the customer’s requirements, expensive technical decisions may already have been locked in.

How customer requirements influence technical development

Customer requirements can flow backwards through the entire production system.

For example:

Customer requirement: A buyer needs an EPA-rich oil with a defined fatty-acid profile and oxidation limits.

That influences:

Product specification

which influences:

Extraction, purification and stabilisation requirements

which may influence:

Harvesting and biomass handling

which can influence:

Cultivation strategy and strain selection.

This connection is particularly important in biotechnology because the biological system and downstream process are not independent.

A strain with very high biomass productivity may not be the best commercial strain if:

• the EPA concentration is too low;
• the fatty-acid profile is wrong;
• extraction is difficult;
• the product is unstable;
• sensory performance is poor;
• recovery is uneconomic.

The commercial target should therefore be a usable finished ingredient, not maximum biological output in isolation.

Regulatory requirements can shape the product

Regulatory status also needs to be considered early.

Requirements differ significantly between countries and applications.

Questions can include:

• Is the organism already recognised for the proposed use?
• Is the ingredient considered novel?
• Does the processing method affect regulatory status?
• What safety data are required?
• What use levels are permitted?
• What claims can be made?
• Is pre-market notification or approval required?

For example, in the United States, certain new dietary ingredients require pre-market notification to the FDA and supporting information demonstrating why the ingredient is reasonably expected to be safe under the proposed conditions of use. ([U.S. Food and Drug Administration][4])

That does not mean the same regulatory pathway applies to every microalgae ingredient or every market.

The relevant lesson is that regulatory strategy cannot safely be left until the end of technical development.

Supply requirements matter too

Product qualification does not stop at laboratory performance.

Customers also need confidence that the supplier can actually supply the ingredient.

Commercial questions can include:

• expected annual volume
• order frequency
• minimum order quantity
• lead time
• batch size
• manufacturing capacity
• inventory policy
• packaging format
• storage
• logistics
• continuity of supply
• change-control procedures

These requirements can affect facility design and production planning.

For example, a customer requiring several small, frequent deliveries may create a very different operating model from one taking large bulk campaigns.

Likewise, a development programme targeting 10 kg qualification batches needs a different production system from one designed for hundreds of tonnes per year.

Scale should therefore follow qualified demand rather than assumed demand.

Why this matters particularly for microalgae ingredients

Microalgae production combines biological variability with engineered process systems.

This makes early definition of the finished product especially valuable.

The supplier has to align:

• organism
• cultivation conditions
• harvesting
• dewatering
• processing
• quality control
• formulation requirements
• packaging
• regulatory strategy
• production scale

Changing one part can affect several others.

That means customer input is not simply commercial feedback after development.

Used properly, it is part of the technical design process.

Where NuFoods Biotech fits

NuFoods Biotech is developing microalgae-derived EPA and other high-value ingredient opportunities from New Zealand.

Its development model is intended to connect customer requirements with measured biological, process and product performance before committing to full commercial scale.

Phase 1 is intended to generate evidence around:

• strain and cultivation performance
• fatty-acid composition
• harvesting and dewatering
• downstream recovery
• product quality
• analytical testing
• stability
• regulatory requirements
• customer specifications
• qualification quantities
• processing economics

The programme is also intended to produce representative customer trial material.

The objective is to use those results and customer feedback to refine the product and production system before Phase 2 commercial investment decisions are made.

NuFoods therefore does not yet claim a final commercial specification, validated large-scale output or completed customer qualification.

Those are development outcomes the staged programme is intended to establish.

FAQ

What is ingredient qualification?

Ingredient qualification is the process through which a customer determines whether an ingredient is suitable for its product and supply chain. It can include technical testing, formulation trials, specification review, quality assessment, regulatory review and commercial evaluation.

What is an ingredient specification?

An ingredient specification defines the characteristics a product must meet, such as identity, composition, physical properties, microbiological limits, contaminants and other quality parameters.

What is the difference between a specification and a Certificate of Analysis?

The specification defines the acceptance requirements for the ingredient. A Certificate of Analysis reports the test results for a specific batch against those requirements.

Why should customer requirements be understood before scale-up?

Customer requirements can influence product composition, processing, analytical testing, regulatory strategy, packaging and production scale. Understanding these requirements early reduces the risk of designing a commercial system around a product customers cannot use.

Why does formulation testing matter?

An ingredient may meet its analytical specification but still perform poorly in the finished product because of flavour, odour, stability, solubility, dispersibility or manufacturing compatibility.

Are regulatory requirements the same for all microalgae ingredients?

No. Regulatory requirements depend on factors such as the organism, production process, ingredient format, intended use, dose and target market.

Does NuFoods already have a final commercial EPA specification?

No. NuFoods is developing its product and production system, and final commercial specifications are intended to be informed by biological performance, downstream processing, analytical testing, regulatory requirements and customer qualification.